MENS

Bullish

Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview

Jyong Biotech's CEO, Ms. Fu-Feng Kuo, detailed the company's FDA pathway and global strategy in a PharmaBoardroom interview. The company is developing...

GlobeNewswire 1 hour ago 0

Neutral

12M Americans have BPH; one biotech is testing a plant-based option

Jyong Biotech is advancing Botreso, a plant-based drug targeting benign prostatic hyperplasia (BPH) with 12.2 million US patients, and a prostate canc...

Stock Titan 1 hour ago 0